In comparison to NSCLC patients, those with SCLC exhibit lower frequencies of PD-L1 expression, compounded by the scarcity of specimen cells which limits PD-L1 detection and research [33]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.